ANKRD20A18P

Across TCGA pan-cancer cohorts, ANKRD20A18P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated ANKRD20A18P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher ANKRD20A18P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ANKRD20A18P expression acts as an unfavorable survival marker, although some lineages such as BLCA and SKCM show a favorable association.

BRCA, ACC, and BLCA are the cancer types where ANKRD20A18P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Quartile	II,III,IV	0.826	0.912	<.001	62	view →
ACC	DFS	Tertile	All	0.387	0.705	.003	43	view →
BLCA	OS	Tertile	III,IV	0.553	0.292	.002	41	view →
SKCM	DFS	Median	All	0.800	0.662	.001	41	view →
COAD	OS	Tertile	III,IV	0.546	0.763	.012	36	view →
KIRP	OS	Tertile	II,III,IV	0.297	0.684	.011	36	view →
LIHC	OS	Tertile	III,IV	0.059	0.738	<.001	36	view →
KIRC	DFS	Tertile	All	0.566	0.679	.014	33	view →
THYM	DFS	Median	II,III,IV	0.901	0.544	.003	26	view →
PCPG	DFS	Tertile	All	0.445	0.822	.006	18	view →
ESCA	OS	Median	IV	0.698	0.222	.006	15	view →
STAD	OS	Median	II,III,IV	0.614	0.725	.013	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

ANKRD20A18P–BRCA (DFS)

Open the BRCA breakdown →